LIPELLA PHARMACEUTICALS INC. cotiza a 0.00 USD y tiene una capitalización bursátil de $2310. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cyst…
| Periodo | 2025-03 | 2024-11 | 2024-08 |
|---|---|---|---|
| Real | $-1.19 | $-1.29 | $-0.96 |
| Estimado | $-2.43 | $-0.96 | $-1.04 |
| Sorpresa | +51.0% | -34.4% | +7.7% |
| Métrica | LIPO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -947.2% | -38.6% | -908.6% |
| Net Margin | -935.3% | -33.6% | -901.7% |
| FCF Margin | — | -13.9% | — |
| ROE | -261.3% | -40.4% | -220.9% |
| ROA | -187.6% | -32.0% | -155.6% |
| Current Ratio | 3.47 | 2.84 | +0.63 |
| Debt / Equity | — | 0.28 | — |